Literature DB >> 28712859

Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-κB.

Jae-Gyu Kim1, Kyoung-Chan Choi2, Chang-Won Hong3, Hwee-Seon Park1, Eun-Kyoung Choi4, Yong-Sun Kim5, Jae-Bong Park6.   

Abstract

Dysregulation of reactive oxygen species (ROS) levels is implicated in the pathogenesis of several diseases, including cancer. However, the molecular mechanisms for ROS in tumorigenesis have not been well established. In this study, hydrogen peroxide activated nuclear factor-κB (NF-κB) and RhoA GTPase. In particular, we found that hydrogen peroxide lead to phosphorylation of RhoA at Tyr42 via tyrosine kinase Src. Phospho-Tyr42 (p-Tyr42) residue of RhoA is a binding site for Vav2, a guanine nucleotide exchange factor (GEF), which then activates p-Tyr42 form of RhoA. P-Tyr42 RhoA then binds to IκB kinase γ (IKKγ), leading to IKKβ activation. Furthermore, RhoA WT and phospho-mimic RhoA, RhoA Y42E, both promoted tumorigenesis, whereas the dephospho-mimic RhoA, RhoA Y42F suppressed it. In addition, hydrogen peroxide induced NF-κB activation and cell proliferation, along with expression of c-Myc and cyclin D1 in the presence of RhoA WT and RhoA Y42E, but not RhoA Y42F. Indeed, levels of p-Tyr42 Rho, p-Src, and p-65 are significantly increased in human breast cancer tissues and show correlations between each of the two components. Conclusively, the posttranslational modification of as RhoA p-Tyr42 may be essential for promoting tumorigenesis in response to generation of ROS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; IKK; ROS; RhoA; Src; Tyr phosphorylation

Mesh:

Substances:

Year:  2017        PMID: 28712859     DOI: 10.1016/j.freeradbiomed.2017.07.013

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

1.  Uterus globulin associated protein 1 (UGRP1) binds podoplanin (PDPN) to promote a novel inflammation pathway during Streptococcus pneumoniae infection.

Authors:  Lei Han; Feifei Zhang; Yu Liu; Jie Yu; Qianyue Zhang; Xiaoping Ye; Huaidong Song; Cuixia Zheng; Bing Han
Journal:  Clin Transl Med       Date:  2022-06

Review 2.  RhoA Signaling in Neurodegenerative Diseases.

Authors:  Sissel Ida Schmidt; Morten Blaabjerg; Kristine Freude; Morten Meyer
Journal:  Cells       Date:  2022-05-01       Impact factor: 7.666

3.  Pyruvate Dehydrogenase A1 Phosphorylated by Insulin Associates with Pyruvate Kinase M2 and Induces LINC00273 through Histone Acetylation.

Authors:  Abu Jubayer Hossain; Rokibul Islam; Jae-Gyu Kim; Oyungerel Dogsom; Kim Cuong Cap; Jae-Bong Park
Journal:  Biomedicines       Date:  2022-05-27

Review 4.  Regulation of RhoA GTPase and novel target proteins for ROCK.

Authors:  Eun-Kyoung Choi; Jae-Gyu Kim; Hee-Jun Kim; Jung-Yoon Cho; Hwalrim Jeong; Yohan Park; Rokibul Islam; Cuong Kim Cap; Jae-Bong Park
Journal:  Small GTPases       Date:  2017-12-03

5.  Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-κB.

Authors:  Yi Zhu; George A Howard; Keith Pittman; Christi Boykin; Laura E Herring; Emily M Wilkerson; Kathryn Verbanac; Qun Lu
Journal:  Mol Cancer Res       Date:  2019-06-12       Impact factor: 6.333

6.  Distinct dual roles of p-Tyr42 RhoA GTPase in tau phosphorylation and ATP citrate lyase activation upon different Aβ concentrations.

Authors:  Kim Cuong Cap; Yeon-Joo Jung; Bo Young Choi; Seung Jae Hyeon; Jae-Gyu Kim; Jung-Ki Min; Rokibul Islam; Abu Jubayer Hossain; Won-Suk Chung; Sang Won Suh; Hoon Ryu; Jae-Bong Park
Journal:  Redox Biol       Date:  2020-01-31       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.